Lumida
/FOLD
⌘K
Amicus Therapeutics Inc

Amicus Therapeutics Inc

FOLD
$14.49USD+0.21%+0.03 today

MARKET CAP

4.5B

P/E (TTM)

FWD P/E

DAY RANGE

$14 – $15

52W RANGE

$6
$15
STATEMENT·Income statement
USD · GAAP
METRICFY 2021FY 2022FY 2023FY 2024FY 2025TREND
Sales, Adj.$305.5M$329.2M$399.4M$528.3M$634.2M
YoY %+17.1%+7.8%+21.3%+32.3%+20.0%
P / Sales10.3x10.5x10.5x5.4x6.9x
EV / Sales11.4x11.8x11.5x6.1x7.7x
Gross Profit, Adj.$271.0M$290.6M$362.0M$475.4M$561.3M
YoY %+17.9%+7.2%+24.6%+31.3%+18.1%
Margin %88.7%88.3%90.7%90.0%88.5%
EV / Gross Profit12.9x13.4x12.6x6.8x8.6x
EBITDA, Adj.$-193.7M$-199.1M$-68.2M$42.6M$42.0M
YoY %+17.6%-2.8%+65.7%+162.5%-1.5%
Margin %-63.4%-60.5%-17.1%8.1%6.6%
EV / EBITDA-18.0x-19.6x-67.1x76.1x115.7x
EBIT$-199.9M$-211.0M$-77.2M$24.9M$32.8M
YoY %+18.0%-5.6%+63.4%+132.2%+31.8%
Margin %-65.4%-64.1%-19.3%4.7%5.2%
EV / EBIT-17.4x-18.5x-59.2x130.4x148.0x
Net Income$-250.5M$-236.6M$-151.6M$-56.1M$-27.1M
YoY %+9.5%+5.5%+35.9%+63.0%+51.7%
Net Margin-82.0%-71.9%-38.0%-10.6%-4.3%
EPS (GAAP)-$0.92-$0.82-$0.51-$0.18-$0.09
YoY %+14.0%+10.9%+37.8%+64.7%+50.0%